| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/11/2001 | WO2001002851A1 Method for screening targeting dds preparation |
| 01/11/2001 | WO2001002551A2 Virus like particles, preparation and use in screening and functional genomics |
| 01/11/2001 | WO2001002478A1 Pre-formed, self-adhesive sheet devices suitable for topical application |
| 01/11/2001 | WO2001002460A1 Biodegradable block copolymers with modifiable surface |
| 01/11/2001 | WO2001002393A1 Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives |
| 01/11/2001 | WO2001002360A1 Process for preparing amlodipine benzenesulphonate |
| 01/11/2001 | WO2001002298A1 Electrolytic purification of calcium carbonate |
| 01/11/2001 | WO2001002029A1 Agent for occluding blood vessels |
| 01/11/2001 | WO2001002024A1 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 01/11/2001 | WO2001002020A2 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 01/11/2001 | WO2001002018A2 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 01/11/2001 | WO2001002017A2 Erythropoietin conjugates with polyethylenglycol |
| 01/11/2001 | WO2001002016A1 Nasogastric enteral formulations |
| 01/11/2001 | WO2001002015A1 Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs |
| 01/11/2001 | WO2001002002A1 Stabilized pharmaceutical composition in lyophilized form |
| 01/11/2001 | WO2001001993A1 A formulation of glucosamine sulphate |
| 01/11/2001 | WO2001001992A1 A solid formulation of glucosamine sulphate |
| 01/11/2001 | WO2001001991A1 Pharmaceutical tablets |
| 01/11/2001 | WO2001001984A1 Levodopa / carbidopa / entacapone pharmaceutical preparation |
| 01/11/2001 | WO2001001967A1 Microreservoir system on the basis of polysiloxanes and ambiphilic solvents |
| 01/11/2001 | WO2001001966A2 Sustained release dosage form unit having latex coating and method of making the same |
| 01/11/2001 | WO2001001965A1 Grf-containing lyophilized pharmaceutical compositions |
| 01/11/2001 | WO2001001963A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001962A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001961A1 Oral micro-emulsion composition of silybin |
| 01/11/2001 | WO2001001960A1 Clear oil-containing pharmaceutical compositions |
| 01/11/2001 | WO2001001958A1 Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip |
| 01/11/2001 | WO2001001955A1 Nasal formulation of an antifungal |
| 01/11/2001 | WO2001001950A1 Pre-formed gel sheet |
| 01/11/2001 | WO2001001940A1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 01/11/2001 | WO2001001939A1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 01/11/2001 | WO2001001932A2 Oligosaccharide aldonic acids and their topical use |
| 01/11/2001 | WO2001001929A2 Microcapsules iv |
| 01/11/2001 | WO2001001928A1 Microcapsules - iii |
| 01/11/2001 | WO2001001927A1 Microcapsules - i |
| 01/11/2001 | WO2001001922A2 Use of substance p antagonists for the treatment of adenocarcinoma |
| 01/11/2001 | WO2001001899A1 Methods and materials for preterm birth prevention |
| 01/11/2001 | WO2000063364A3 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 01/11/2001 | WO2000062801A3 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 01/11/2001 | WO2000061543A3 Esters of l-carnitine or alkanoyl l-carnitines |
| 01/11/2001 | WO2000061189A3 Water-soluble compositions of bioactive lipophilic compounds |
| 01/11/2001 | WO2000057851A3 High potency dihydroergotamine compositions |
| 01/11/2001 | WO2000055208A3 Chimeric toxins |
| 01/11/2001 | WO2000051603A3 Compositions of remifentanil |
| 01/11/2001 | DE19931667A1 Flexible, water-soluble or water-dispersible coating agent, binder or film former for pharmaceutical formulations, comprises new or known vinyl ester-polyether graft copolymer, |
| 01/11/2001 | DE19930729A1 Blockcopolymere zur Herstellung biomimetischer Oberflächen Block copolymers for the preparation of biomimetic surfaces |
| 01/11/2001 | DE19930177A1 Intermolekular assoziierende Verbindungen und diese umfassende Aggregate Inter-molecular compounds and associating this comprehensive aggregates |
| 01/11/2001 | DE19929511A1 Concentrated, free-flowing aqueous anionic surfactant mixture containing alkyl ether sulfate and alkyl sulfate, used in cosmetic of pharmaceutical formulations, especially shampoos |
| 01/11/2001 | CA2378606A1 Agent for occluding blood vessels |
| 01/11/2001 | CA2378525A1 A solid formulation of glucosamine sulphate |
| 01/11/2001 | CA2378521A1 Pharmaceutical tablets |
| 01/11/2001 | CA2375748A1 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 01/11/2001 | CA2375157A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | CA2375085A1 Sustained release dosage form unit having latex coating and method of making the same |
| 01/11/2001 | CA2373979A1 Pre-formed gel sheet |
| 01/11/2001 | CA2373960A1 Use of substance p antagonists for the treatment of adenocarcinoma |
| 01/11/2001 | CA2373081A1 Electrolytic purification of calcium carbonate |
| 01/11/2001 | CA2341984A1 Complexes of paroxetine, with cyclodextrines or cyclodextrin derivatives |
| 01/10/2001 | EP1066836A1 Filler/binder hollow particles for tablets |
| 01/10/2001 | EP1066829A1 Stable microemulsions for administration of fatty acids, and use thereof |
| 01/10/2001 | EP1066828A1 Medicaments |
| 01/10/2001 | EP1066822A1 Composition for treating dandruffs in hair and scalp based on an antidandruff agent and a hydroxy-acid |
| 01/10/2001 | EP1066816A1 Agents promoting laminin production in skin cells |
| 01/10/2001 | EP1066761A2 Compositions containing fat-soluble substances in a carbohydrate matrix |
| 01/10/2001 | EP1066380A2 Soluble t cell receptor |
| 01/10/2001 | EP1066305A2 Sucrose-n-alkyl-asparaginates, production and use thereof |
| 01/10/2001 | EP1066059A1 Formulations for protection of peg-interferon alpha conjugates |
| 01/10/2001 | EP1066058A1 Methods and means for the treatment of immune related diseases |
| 01/10/2001 | EP1066057A1 Hemoglobin-polysaccharide conjugates |
| 01/10/2001 | EP1066056A1 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
| 01/10/2001 | EP1066054A2 Use of active p40 conjugates for nasal delivery |
| 01/10/2001 | EP1066049A1 Pharmaceutical compositions for prolonged peptide release and preparation method |
| 01/10/2001 | EP1066040A1 Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption |
| 01/10/2001 | EP1066031A2 Method for the production of micro capsules |
| 01/10/2001 | EP1066030A1 Topical hormonal composition with systemic effect |
| 01/10/2001 | EP1066029A1 Peroral active agent suspension |
| 01/10/2001 | EP1066027A1 Pharmaceutical composition of topiramate |
| 01/10/2001 | EP1066004A1 Steam-generating pad |
| 01/10/2001 | EP1065946A1 Natural substance based agent |
| 01/10/2001 | EP1065936A1 Encapsulation of components into edible products |
| 01/10/2001 | EP0946637B1 Polymer film compositions for capsules |
| 01/10/2001 | EP0862439A4 Ligands to enhance cellular uptake of biomolecules |
| 01/10/2001 | CN1279701A Gelatine compositions |
| 01/10/2001 | CN1279607A Anaesthetic formulation |
| 01/10/2001 | CN1279112A Composition with carbohydrate matrix containing liposoluble substance |
| 01/10/2001 | CN1279036A Method and composition for extending sevice life of intestinal canal |
| 01/10/2001 | CN1060487C Silicone grafted thermoplatic elastomeric copolymers and hair and skin care compositions containing the same |
| 01/09/2001 | US6172261 Biosynthesis using chain extension |
| 01/09/2001 | US6172219 Esterification, lactonization, salt formation; cosmetics, food packaging, drug carriers |
| 01/09/2001 | US6172208 Oligonucleotides modified with conjugate groups |
| 01/09/2001 | US6172202 Synthesis of polymer bio-active conjugates |
| 01/09/2001 | US6172201 Cellular receptor for HIV-1 Vpr essential for G2/M phase |
| 01/09/2001 | US6172059 Controlling particle size |
| 01/09/2001 | US6172049 Supplying macromolecules to cells |
| 01/09/2001 | US6172045 Cluster clearing agents |
| 01/09/2001 | US6172040 Meat microbiocide |
| 01/09/2001 | US6171778 Using solution containing arabinogalactan to remove impurities and protect viability |
| 01/09/2001 | US6171619 Spherical granule, process for producing the same, and spherical granule preparations using the same |
| 01/09/2001 | US6171618 Combination dosage form comprising cetirizine and pseudoephedrine |
| 01/09/2001 | US6171613 Method for producing liposomes with increased percent of compound encapsulated |